| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.0029 | 1 |